Pneumonia caused by oxacillin-resistant Staphylococcus aureus treated with glycopeptides*

Despite appropriate glycopeptide therapy, there is an increased attributable mortality for pneumonia by ORSA, after careful adjustment for disease severity and diagnostic category.